Financial News

Apricus Biosc Inc (NQ: APRI )

0.2201 USD UNCHANGED

Last Price Updated: 6:11 PM EST, Jan 23, 2019 Add to My Watchlist

Price and Volume

Volume	0
Open	0.2201
Bid (Size)	0.1900 (70)
Ask (Size)	0.2600 (150)
Prev. Close	0.2201
Today's Range	0.2201 - 0.2201
52wk Range	0.3000 - 0.3749
Shares Outstanding	102,315,208
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Seelos Therapeutics, Inc. Announces Successful Completion of its Merger with Apricus Biosciences, Inc. to Advance Late-Stage Pipeline of Products for Central Nervous System (CNS) Disorders

January 24, 2019

Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development and advancement of novel therapeutics to address unmet medical needs for the benefit of...

Apricus Biosciences Stockholders Approve Proposed Merger with Seelos Therapeutics, Inc.

January 14, 2019

Merger Expected to Close in January 2019

Performance

YTD	-26.63%	-26.63%
1 Month	-26.63%	-26.63%
3 Month	-26.63%	-26.63%
6 Month	-26.63%	-26.63%
1 Year	-26.63%	-26.63%

More News

Apricus Biosciences Adjourns Special Meeting of Stockholders to New Date

December 14, 2018

Apricus Biosciences Reminds Shareholders to Vote Before the Special Meeting on December 14, 2018

December 09, 2018

Report: Exploring Fundamental Drivers Behind Zedge, Apricus Biosciences, AquaBounty Technologies, Clarus, Dynasil Corporation of America, and The Rubicon Project — New Horizons, Emerging Trends, and U

November 16, 2018

Apricus Biosciences Provides Corporate Update and Third Quarter 2018 Financial Results

October 31, 2018

Apricus Biosciences Provides Corporate Update and Second Quarter 2018 Financial Results

August 09, 2018

Apricus Biosciences, Inc. Announces Merger Agreement with Seelos Therapeutics, Inc. to Advance Late-Stage Pipeline of Products for Central Nervous System (CNS) Disorders

July 30, 2018

Quotidian Technical Highlights on Selected Drug Makers Stocks -- Amarin, Apricus Biosciences, Depomed, and DURECT

April 24, 2018

The Daily Biotech Pulse: Intuitive Surgical Earnings, Corbus To Offer Shares, Eton In-Licenses Neurologic Drug

January 24, 2019

BRIEF-Apricus Biosciences Says Co Received A Nasdaq Staff Deficiency Letter

April 16, 2018

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Financial News

Apricus Biosc Inc (NQ: APRI )

Price and Volume

Top News

Performance

More News

Popular Pages